Literature DB >> 9045856

Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice.

C I Berul1, M E Christe, M J Aronovitz, C E Seidman, J G Seidman, M E Mendelsohn.   

Abstract

A new mouse cardiac electrophysiology method was used to study mice harboring an alpha-myosin heavy chain Arg403Gln missense mutation (alpha-MHC403/+), which results in histological and hemodynamic abnormalities characteristic of familial hypertrophic cardiomyopathy (FHC) and sudden death of uncertain etiology during exercise. Wild-type animals had completely normal cardiac electrophysiology. In contrast, FHC mice demonstrated (a) electrocardiographic abnormalities including prolonged repolarization intervals and rightward axis; (b) electrophysiological abnormalities including heterogeneous ventricular conduction properties and prolonged sinus node recovery time; and (c) inducible ventricular ectopy. These data identify distinct electrophysiologic abnormalities in FHC mice with a specific alpha-myosin mutation, and also validate a novel method to explore in vivo the relationship between specific genotypes and their electrophysiologic phenotypes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9045856      PMCID: PMC507836          DOI: 10.1172/JCI119197

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment.

Authors:  E D Wigle; H Rakowski; B P Kimball; W G Williams
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

2.  Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death.

Authors:  G Buja; M Miorelli; P Turrini; P Melacini; A Nava
Journal:  Am J Cardiol       Date:  1993-10-15       Impact factor: 2.778

Review 3.  The prognostic significance of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Authors:  W J McKenna; N Sadoul; A K Slade; R C Saumarez
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

4.  Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene.

Authors:  S D Solomon; S Wolff; H Watkins; P M Ridker; P Come; W J McKenna; C E Seidman; R T Lee
Journal:  J Am Coll Cardiol       Date:  1993-08       Impact factor: 24.094

5.  Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia.

Authors:  P Spirito; C Rapezzi; C Autore; P Bruzzi; P Bellone; P Ortolani; P V Fragola; F Chiarella; M Zoni-Berisso; A Branzi
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

6.  Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children.

Authors:  C I Berul; T L Sweeten; A M Dubin; M J Shah; V L Vetter
Journal:  Am J Cardiol       Date:  1994-12-15       Impact factor: 2.778

Review 7.  A miracle enough: the power of mice.

Authors:  K Paigen
Journal:  Nat Med       Date:  1995-03       Impact factor: 53.440

8.  Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

Authors:  C R Cannan; G S Reeder; K R Bailey; L J Melton; B J Gersh
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

9.  A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy.

Authors:  H Watkins; R Anan; D A Coviello; P Spirito; J G Seidman; C E Seidman
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

10.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy.

Authors:  H Watkins; W J McKenna; L Thierfelder; H J Suk; R Anan; A O'Donoghue; P Spirito; A Matsumori; C S Moravec; J G Seidman
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

View more
  24 in total

Review 1.  Molecular biology of human arrhythmias: implications for the clinical electrophysiologist.

Authors:  N A Estes; M E Mendelsohn
Journal:  J Interv Card Electrophysiol       Date:  1998-12       Impact factor: 1.900

2.  Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin.

Authors:  B C Knollmann; B E Knollmann-Ritschel; N J Weissman; L R Jones; M Morad
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

Review 3.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

4.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

5.  Early remodeling of repolarizing K+ currents in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy.

Authors:  Rocco Hueneke; Adam Adenwala; Rebecca L Mellor; Jonathan G Seidman; Christine E Seidman; Jeanne M Nerbonne
Journal:  J Mol Cell Cardiol       Date:  2017-01-13       Impact factor: 5.000

6.  Non-invasive restrained ECG recording in conscious small rodents: a new tool for cardiac electrical activity investigation.

Authors:  H Mongue-Din; A Salmon; M Y Fiszman; Y Fromes
Journal:  Pflugers Arch       Date:  2007-01-17       Impact factor: 3.657

7.  Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities.

Authors:  C I Berul; M E Christe; M J Aronovitz; C T Maguire; C E Seidman; J G Seidman; M E Mendelsohn
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

8.  Cardiac electrophysiology and the susceptibility to sustained ventricular tachycardia in intact, conscious mice.

Authors:  Heidi L Lujan; Stephen E DiCarlo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

Review 9.  Sex related differences in the pathogenesis of organ fibrosis.

Authors:  Alejandra Garate-Carrillo; Julisa Gonzalez; Guillermo Ceballos; Israel Ramirez-Sanchez; Francisco Villarreal
Journal:  Transl Res       Date:  2020-03-16       Impact factor: 7.012

10.  Reversibility of PRKAG2 glycogen-storage cardiomyopathy and electrophysiological manifestations.

Authors:  Cordula M Wolf; Michael Arad; Ferhaan Ahmad; Atsushi Sanbe; Scott A Bernstein; Okan Toka; Tetsuo Konno; Gregory Morley; Jeffrey Robbins; J G Seidman; Christine E Seidman; Charles I Berul
Journal:  Circulation       Date:  2007-12-24       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.